Viral acute lower respiratory infections rapidly impair CD8+ T lymphocyte functions through the PD-1/PD-L1 pathway (105.44)

John J. Erickson(Vanderbilt University), John M. Williams(Royal Hospital for Children), Sebastian Joyce(Walther Cancer Foundation), Melissa Downing(Bipar), Sharon J. Tollefson(Vanderbilt University), J. Erik Johnson(Vanderbilt University), Andrew K. Hastings(Bipar), Kelli L. Boyd(Vanderbilt University Medical Center), Pavlo Gilchuk(AstraZeneca (Japan))
The Journal of Immunology
May 1, 2012
10.4049/jimmunol.188.supp.105.44
Cited by 0

Related Papers

Potently neutralizing and protective human antibodies against SARS-CoV-2
|Nature|2020|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1
|Immunity|2009|750
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543